SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Astal Laboratories Ltd

BSE: 512600 NSE: ISIN: INE307N01014
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Astal Laboratories Ltd belong to?
Astal Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Astal Laboratories Ltd a good quality company?
Astal Laboratories Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Astal Laboratories Ltd undervalued or overvalued?
Astal Laboratories Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Astal Laboratories Ltd a good buy now?
Astal Laboratories Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Astal Laboratories Ltd?
Astal Laboratories Ltd revenue growth is 171.6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.2 Gross Profit margin of Astal Laboratories Ltd?
Astal Laboratories Ltd Gross profit margin which is the profit after deduction of direct costs, is 19% for FY-2025 , which is above its 5 year median of 1.2% , indicating increasing margins.
Q.3 Operating Profit Margin of Astal Laboratories Ltd?
Astal Laboratories Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 19.89% for FY-2025 , which is above its 5 year median of 0% indicating increasing margins.
Q.4 Net Profit Margin of Astal Laboratories Ltd?
Astal Laboratories Ltd Net Profit Margin is 13.9% for FY-2025 , is above with its 5 year median of 0.48%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 19 1.2
Operating Profit Margin 19.89 -
Net Profit Margin 13.9 0.48
Q.5 Return on Asset of Astal Laboratories Ltd?
Astal Laboratories Ltd Return on Asset is 17.86(x), which is above its 5 year historical median of 0.22(x), indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Astal Laboratories Ltd?
Astal Laboratories Ltd Return on equity is 32.12% for FY-2025 , which is above its historical median of 0.32%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Astal Laboratories Ltd?
Astal Laboratories Ltd Return on capital employed is 34.78% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Astal Laboratories Ltd?
Astal Laboratories Ltd Cash conversion cycle is 87 , above its historical median of 0 , indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.29 0.45
ROE 32.12 0.32
ROCE 34.78 0.62
Cash Conversion Cycle 87 -
Q.9 Debt to Equity ratio of Astal Laboratories Ltd?
Astal Laboratories Ltd Debt-to-Equity ratio is 0.41 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Astal Laboratories Ltd?
Astal Laboratories Ltd Debt to cash flow from operations is -1.06 , which is at a unhealthy level, indicating the business is not able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Astal Laboratories Ltd?
Promoters hold 18.19% of the Astal Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Astal Laboratories Ltd vs industry peers?
Astal Laboratories Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 64.2 137.1
Gross Profit 12.2 15.1
Operating Profit 13 16
Net Profit 9 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.29 0.8
ROE 32.12 8.91
ROCE 34.78 11.59
Cash Conversion Cycle 87.46 76

Valuation & price assessment

Q.1 Stock return of Astal Laboratories Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 11.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 11.8% 50.4% 29.4% -22.7%
Q.3 Valuation ratios of Astal Laboratories Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 29.05 0.00 40.28
Price to Book 3.53 2.45 2.77
Price to Sales 2.05 0.00 2.65
EV to EBITDA 19.55 66.77 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Pfizer
6. Wockhardt
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Acutaas Chemicals
10. Piramal Pharma
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×